0001127602-19-010077.txt : 20190305
0001127602-19-010077.hdr.sgml : 20190305
20190305191540
ACCESSION NUMBER: 0001127602-19-010077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190305
DATE AS OF CHANGE: 20190305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Colleran David
CENTRAL INDEX KEY: 0001646558
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 19660630
MAIL ADDRESS:
STREET 1: 600 TECHNOLOGY PARK DRIVE
STREET 2: SUITE 200
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
BUSINESS PHONE: 978-600-7000
MAIL ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-03-01
0001145197
INSULET CORP
PODD
0001646558
Colleran David
C/O INSULET CORPORATION
100 NAGOG PARK
ACTON
MA
01720
1
SVP, Secretary and GC
Common Stock
2019-03-01
4
M
0
16639
30.98
A
47072
D
Common Stock
2019-03-01
4
M
0
1166
29.26
A
48238
D
Common Stock
2019-03-01
4
M
0
1422
46.22
A
49660
D
Common Stock
2019-03-01
4
M
0
1748
74.50
A
51408
D
Common Stock
2019-03-01
4
S
0
20975
94.6536
D
30433
D
Employee Stock Option (Right to Buy)
30.98
2019-03-01
4
M
0
16639
0
D
2025-06-29
Common Stock
16639
11093
D
Employee Stock Option (Right to Buy)
29.26
2019-03-01
4
M
0
1166
0
D
2026-02-24
Common Stock
1166
5831
D
Employee Stock Option (Right to Buy)
46.22
2019-03-01
4
M
0
1422
0
D
2027-02-22
Common Stock
1422
5686
D
Employee Stock Option (Right to Buy)
74.50
2019-03-01
4
M
0
1748
0
D
2028-02-14
Common Stock
1748
5247
D
Includes 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest as to one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $94.37 to $94.99. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
/s/ David Colleran
2019-03-05